Second American infected with Ebola en route to US

Dr. Kent Brantly and his wife, Amber, are seen in an undated photo provided by Samaritan's Purse. Brantly became the first person infected with Ebola to be brought to the United States from Africa, arriving at at Emory University Hospital, in Atlanta on Saturday, Aug. 2, 2014. Fellow aid worker Nancy Writebol was expected to arrive in several days. (AP Photo/Samaritan's Purse)

The second American aid worker recently diagnosed with Ebola in west Africa is en route to Atlanta.

A chartered plane specially equipped to contain took off at 1:12 a.m. local time (9:12 p.m. EDT Monday) from the airport in Liberia's capital, Monrovia. An Associated Press reporter saw the four-vehicle convoy arrive at the airport.

Although hospital officials haven't released the patient's identity, the aid group she was working with has identified her as 59-year-old Nancy Writebol.

Writebol will be treated at a special isolation unit at Emory University Hospital in Atlanta. Dr. Kent Brantly was taken to the unit Saturday after arriving from Liberia aboard the same aircraft.

Brantly and Writebol contracted Ebola while treating patients at a missionary clinic in Liberia.

Both are being treated with an experimental drug never tested for safety in humans.

Related Stories

Recommended for you

Score IDs patients with upper extremity DVT at low risk

date 10 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

date 21 hours ago

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

date 21 hours ago

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.